metoclopramide has been researched along with td-5108 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Barberich, TJ; Hewitt, MC; Shao, L; Wang, F | 1 |
Sanger, GJ | 1 |
B, H; Cata, J; Chung, M; Mc, C; Roldan, CJ | 1 |
Fehse, C; Gergs, U; Hofmann, B; Marušáková, M; Neumann, J; Seidler, T | 1 |
1 review(s) available for metoclopramide and td-5108
Article | Year |
---|---|
Translating 5-HT receptor pharmacology.
Topics: Aged; Animals; Benzofurans; Dopamine Antagonists; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Metoclopramide; Receptors, G-Protein-Coupled; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists | 2009 |
3 other study(ies) available for metoclopramide and td-5108
Article | Year |
---|---|
mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).
Topics: Analgesics, Opioid; Cisapride; Gastrointestinal Transit; Humans; Metoclopramide; Receptors, Opioid, mu; Receptors, Serotonin, 5-HT4; Respiratory System; Serotonin 5-HT4 Receptor Agonists; Stereoisomerism; Tramadol | 2009 |
High-flow oxygen and pro-serotonin agents for non-interventional treatment of post-dural-puncture headache.
Topics: Adult; Aged; Conservative Treatment; Female; Humans; Male; Metoclopramide; Middle Aged; Oxygen Inhalation Therapy; Post-Dural Puncture Headache; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists; Treatment Outcome | 2020 |
Cardiovascular effects of metoclopramide and domperidone on human 5-HT
Topics: Aged; Animals; Calcium-Binding Proteins; Cardiovascular Agents; Domperidone; Dopamine Antagonists; Heart; Humans; In Vitro Techniques; Male; Metoclopramide; Mice, Transgenic; Middle Aged; Myocardial Contraction; Myocytes, Cardiac; Phosphorylation; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists | 2021 |